A Comprehensive Spectroscopic and Computational Investigation to Probe the Interaction of Antineoplastic Drug Nordihydroguaiaretic Acid with Serum Albumins

Abstract

Exogenous drugs that are used as antidote against chemotheray, inflammation or viral infection, gets absorbed and interacts reversibly to the major serum transport protein i.e. albumins, upon entering the circulatory system. To have a structural guideline in the rational drug designing and in the synthesis of drugs with greater efficacy, the binding mechanism of an antineoplastic and anti-inflammatory drug Nordihydroguaiaretic acid (NDGA) with human and bovine serum albumins (HSA & BSA) were examined by spectroscopic and computational methods. NDGA binds to site II of HSA with binding constant (Kb) ~105 M-1 and free energy (ΔG) ~ -7.5 kcal.mol-1. It also binds at site II of BSA but with lesser binding affinity (Kb) ~105 M-1 and ΔG ~ -6.5 kcal.mol-1. The negative value of ΔG, ΔH and ΔS for both the albumins at three different temperatures confirmed that the complex formation process between albumins and NDGA is spontaneous and exothermic. Furthermore, hydrogen bonds and hydrophobic interactions are the main forces involved in complex formation of NDGA with both the albumins as evaluated from fluorescence and molecular docking results. Binding of NDGA to both the albumins alter the conformation and causes minor change in the secondary structure of proteins as indicated by the CD spectra.

A biophysical and computational study unraveling the molecular interaction mechanism of a new Janus kinase inhibitor Tofacitinib with bovine serum albumin

“…Dynamic and static quenching is also discriminated because of their dependency on temperature and viscosity. The values for the diffusion coefficient increase with rise in temperature resulting in higher dynamic quenching constant value, while poorly bound complexes gets destabilized at higher temperature and thus the values for the static quenching constant decrease …”

Exploring the interactions of a Tb(III)–quercetin complex with serum albumins (HSA and BSA): spectroscopic and molecular docking studies

“…FRET occurs only when the distance ( r ) between the donor and acceptor molecules is 10–100 Å and there is enough of an overlap between the emission spectrum and the absorption spectrum of the donor and acceptor molecules, respectively. This technique in biochemistry is widely used to determine the distance ( r ) between the donor (the fluorophores) and acceptor (ligands) molecules during protein–ligand interaction . The spectral overlaps between the fluorescence emission spectra of HSA/BSA and the absorption spectrum of the Tb–QUE complex are shown in Figure (a) and (b), respectively.…”

Investigation of the interaction of aurantio‐obtusin with human serum albumin by spectroscopic and molecular docking methods

“…The fluorescence spectroscopic technique offers many advantages, such as sensitivity, accuracy, rapidity, making it an appropriate choice for monitoring ligand binding to serum albumin. The binding mechanisms of albumin to ligand can be worked out by measuring the quench of albumin's natural fluorescence . As can be seen in Figure , the emission spectra of native HSA exhibited an emission maximum at 339 nm, upon excitation at 295 nm and the fluorescence emission maximum of HAS significantly lowered with a gradual increase in aurantio‐obtusin concentrations.…”